The following data is part of a premarket notification filed by Bio-rad Laboratories, Inc. with the FDA for Bio-rad Variant Nbs Sickle Cell Program.
Device ID | K051072 |
510k Number | K051072 |
Device Name: | BIO-RAD VARIANT NBS SICKLE CELL PROGRAM |
Classification | Abnormal Hemoglobin Quantitation |
Applicant | BIO-RAD LABORATORIES, INC. 4000 ALFRED NOBEL DR. Hercules, CA 94547 |
Contact | William G Gustafson |
Correspondent | Alfred J Quattrone CALIFORNIA DEPARTMENT OF HEALTH SERVICES P.O. BOX 997 413 FDB MAILSTOP 7602 Sacramento, CA 95899 -7413 |
Product Code | GKA |
CFR Regulation Number | 864.7415 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | Yes |
Combination Product | No |
Date Received | 2005-04-26 |
Decision Date | 2005-05-12 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00847817008351 | K051072 | 000 |
00847817008344 | K051072 | 000 |
00847817008313 | K051072 | 000 |
00847817008306 | K051072 | 000 |
00847817008283 | K051072 | 000 |
00847817008276 | K051072 | 000 |
00847817007354 | K051072 | 000 |